We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Shopify, Lowe's, CVS Health, Moderna and The Bank of New York Mellon
Read MoreHide Full Article
For Immediate Release
Chicago, IL – July 8, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Shopify Inc. (SHOP - Free Report) , Lowe's Companies, Inc. (LOW - Free Report) , CVS Health Corporation (CVS - Free Report) , Moderna, Inc. (MRNA - Free Report) and The Bank of New York Mellon Corporation (BK - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Top Research Reports for Shopify, Lowe's and CVS Health
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Shopify, Lowe's Companies, and CVS Health. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Shares of Shopify have outperformed the Zacks Internet Services industry in the year-to-date period (+35.9% vs. +35.4%). The Zacks analyst believes that the company is benefiting from the e-commerce boom induced growth in the merchant base. Further, an uptick in Shopify Shipping, Shopify Payments and Shopify Capital has been driving the top line.
Also, solid adoption of new merchant-friendly applications holds promise. Additionally, partnerships with Facebook and Google are expected to expand merchant base. However, higher investments on product development and fulfillment platform amid stiff competition in the e-commerce space are likely to limit margin expansion in the near term.
Lowe's shares have gained +18.8% over the last six months against the Zacks Building Products - Retail industry's gain of +15.3%. The Zacks analyst believes that the company remains well positioned to capitalize the demand in the home improvement market backed by investments in technology, merchandise category and strength in Pro business.
Also, its new total home strategy that includes providing complete solutions for various types of home repair and improvement needs, bodes well. The strategy is an extension of the company's retail-fundamentals approach. Moreover, the management is also committed toward expanding market share and boosting operating margin expansion.
Shares of CVS Health have gained +10.1% in the past three months against the Zacks Retail Pharmacies and Drug Stores industry's gain of +3.5%. The Zacks analyst is encouraged by the increasing demand for PBM and specialty pharmacy as well as significant growth in the retail business.
Meanwhile, consumer-centric digital strategy has become more relevant in the current environment as people are using technology more while staying indoors. In the first quarter, the company achieved higher levels of engagement across digital assets. However, a weak cough, cold and flu season impacted growth within both Pharmacy Services and Retail/LTC.
Other noteworthy reports we are featuring today include Moderna and The Bank of New York Mellon.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It's bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is "Will you get into the right stocks early when their growth potential is greatest?"
Zacks has released a Special Report to help you do just that, and today it's free. Discover 7 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Shopify, Lowe's, CVS Health, Moderna and The Bank of New York Mellon
For Immediate Release
Chicago, IL – July 8, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Shopify Inc. (SHOP - Free Report) , Lowe's Companies, Inc. (LOW - Free Report) , CVS Health Corporation (CVS - Free Report) , Moderna, Inc. (MRNA - Free Report) and The Bank of New York Mellon Corporation (BK - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Top Research Reports for Shopify, Lowe's and CVS Health
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Shopify, Lowe's Companies, and CVS Health. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today's research reports here >>>
Shares of Shopify have outperformed the Zacks Internet Services industry in the year-to-date period (+35.9% vs. +35.4%). The Zacks analyst believes that the company is benefiting from the e-commerce boom induced growth in the merchant base. Further, an uptick in Shopify Shipping, Shopify Payments and Shopify Capital has been driving the top line.
Also, solid adoption of new merchant-friendly applications holds promise. Additionally, partnerships with Facebook and Google are expected to expand merchant base. However, higher investments on product development and fulfillment platform amid stiff competition in the e-commerce space are likely to limit margin expansion in the near term.
(You can read the full research report on Shopify here >>>)
Lowe's shares have gained +18.8% over the last six months against the Zacks Building Products - Retail industry's gain of +15.3%. The Zacks analyst believes that the company remains well positioned to capitalize the demand in the home improvement market backed by investments in technology, merchandise category and strength in Pro business.
Also, its new total home strategy that includes providing complete solutions for various types of home repair and improvement needs, bodes well. The strategy is an extension of the company's retail-fundamentals approach. Moreover, the management is also committed toward expanding market share and boosting operating margin expansion.
(You can read the full research report on Lowe's here >>>)
Shares of CVS Health have gained +10.1% in the past three months against the Zacks Retail Pharmacies and Drug Stores industry's gain of +3.5%. The Zacks analyst is encouraged by the increasing demand for PBM and specialty pharmacy as well as significant growth in the retail business.
Meanwhile, consumer-centric digital strategy has become more relevant in the current environment as people are using technology more while staying indoors. In the first quarter, the company achieved higher levels of engagement across digital assets. However, a weak cough, cold and flu season impacted growth within both Pharmacy Services and Retail/LTC.
(You can read the full research report on CVS Health here >>>)
Other noteworthy reports we are featuring today include Moderna and The Bank of New York Mellon.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It's bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is "Will you get into the right stocks early when their growth potential is greatest?"
Zacks has released a Special Report to help you do just that, and today it's free. Discover 7 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How to Profit from Trillions on Spending for Infrastructure >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.